213 related articles for article (PubMed ID: 21647200)
21. Slit2/Robo1 Mitigates DSS-induced Ulcerative Colitis by Activating Autophagy in Intestinal Stem Cell.
Xie J; Li L; Deng S; Chen J; Gu Q; Su H; Wen L; Wang S; Lin C; Qi C; Zhang Q; Li J; He X; Li W; Wang L; Zheng L
Int J Biol Sci; 2020; 16(11):1876-1887. PubMed ID: 32398956
[TBL] [Abstract][Full Text] [Related]
22. Mucin-1 expression and localization in epithelial cells shows characteristic and distinct patterns in inflammatory bowel diseases and colorectal cancer.
Khemiri M; Doghri R; Mrad K; Friedrich K; Oueslati R
Int J Clin Exp Pathol; 2019; 12(5):1731-1737. PubMed ID: 31933991
[TBL] [Abstract][Full Text] [Related]
23.
Huang R; Wang K; Gao L; Gao W
Onco Targets Ther; 2019; 12():8895-8904. PubMed ID: 31802901
[TBL] [Abstract][Full Text] [Related]
24. Mutant p53 in colon cancer.
Nakayama M; Oshima M
J Mol Cell Biol; 2019 Apr; 11(4):267-276. PubMed ID: 30496442
[TBL] [Abstract][Full Text] [Related]
25. Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.
Beggs AD; James J; Caldwell G; Prout T; Dilworth MP; Taniere P; Iqbal T; Morton DG; Matthews G
Inflamm Bowel Dis; 2018 Jun; 24(7):1503-1509. PubMed ID: 29762666
[TBL] [Abstract][Full Text] [Related]
26. Contribution of ATOH1
Ishibashi F; Shimizu H; Nakata T; Fujii S; Suzuki K; Kawamoto A; Anzai S; Kuno R; Nagata S; Ito G; Murano T; Mizutani T; Oshima S; Tsuchiya K; Nakamura T; Watanabe M; Okamoto R
Stem Cell Reports; 2018 Jan; 10(1):27-42. PubMed ID: 29233556
[TBL] [Abstract][Full Text] [Related]
27. Precancer in ulcerative colitis: the role of the field effect and its clinical implications.
Baker KT; Salk JJ; Brentnall TA; Risques RA
Carcinogenesis; 2018 Jan; 39(1):11-20. PubMed ID: 29087436
[TBL] [Abstract][Full Text] [Related]
28. Nuclear Magnetic Resonance-Based Metabolomics Approach to Evaluate the Prevention Effect of
Li MH; Du HZ; Kong GJ; Liu LB; Li XX; Lin SS; Jia AQ; Yuan ST; Sun L; Wang JS
Front Pharmacol; 2017; 8():447. PubMed ID: 28744216
[TBL] [Abstract][Full Text] [Related]
29. Clonal evolution of colorectal cancer in IBD.
Choi CR; Bakir IA; Hart AL; Graham TA
Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):218-229. PubMed ID: 28174420
[TBL] [Abstract][Full Text] [Related]
30. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
[TBL] [Abstract][Full Text] [Related]
31. Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.
Viennois E; Merlin D; Gewirtz AT; Chassaing B
Cancer Res; 2017 Jan; 77(1):27-40. PubMed ID: 27821485
[TBL] [Abstract][Full Text] [Related]
32. SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development.
Gagné-Sansfaçon J; Coulombe G; Langlois MJ; Langlois A; Paquet M; Carrier J; Feng GS; Qu CK; Rivard N
Oncotarget; 2016 Oct; 7(40):65676-65695. PubMed ID: 27582544
[TBL] [Abstract][Full Text] [Related]
33. Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.
Viennois E; Ingersoll SA; Ayyadurai S; Zhao Y; Wang L; Zhang M; Han MK; Garg P; Xiao B; Merlin D
Cell Mol Gastroenterol Hepatol; 2016 May; 2(3):340-357. PubMed ID: 27458604
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia.
Shivakumar BM; Chakrabarty S; Rotti H; Seenappa V; Rao L; Geetha V; Tantry BV; Kini H; Dharamsi R; Pai CG; Satyamoorthy K
BMC Cancer; 2016 Apr; 16():271. PubMed ID: 27080994
[TBL] [Abstract][Full Text] [Related]
35. The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.
Koblansky AA; Truax AD; Liu R; Montgomery SA; Ding S; Wilson JE; Brickey WJ; Mühlbauer M; McFadden RM; Hu P; Li Z; Jobin C; Lund PK; Ting JP
Cell Rep; 2016 Mar; 14(11):2562-75. PubMed ID: 26971998
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis.
Ro SH; Xue X; Ramakrishnan SK; Cho CS; Namkoong S; Jang I; Semple IA; Ho A; Park HW; Shah YM; Lee JH
Elife; 2016 Feb; 5():e12204. PubMed ID: 26913956
[TBL] [Abstract][Full Text] [Related]
37. Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia.
Horvath B; Singh P; Xie H; Thota PN; Sun X; Liu X
Gastroenterol Rep (Oxf); 2016 Nov; 4(4):304-309. PubMed ID: 26486567
[TBL] [Abstract][Full Text] [Related]
38. Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.
Marshall DC; Lyman SK; McCauley S; Kovalenko M; Spangler R; Liu C; Lee M; O'Sullivan C; Barry-Hamilton V; Ghermazien H; Mikels-Vigdal A; Garcia CA; Jorgensen B; Velayo AC; Wang R; Adamkewicz JI; Smith V
PLoS One; 2015; 10(5):e0127063. PubMed ID: 25961845
[TBL] [Abstract][Full Text] [Related]
39. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
40. Dietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitis.
Saxena A; Kaur K; Hegde S; Kalekhan FM; Baliga MS; Fayad R
J Tradit Complement Med; 2014 Oct; 4(4):203-17. PubMed ID: 25379461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
